|
FDA Approves New Inhaler HFA Formulation for Asthma – Canada Drugs Online News
Market Press Release (press release) ProAir HFA provides you a fast relief when experiencing asthma, exercise-induced bronchospasm (EIB) and chronic obstructive pulmonary disease (COPD). It contains albuterol and is prescribed to patients not younger than 4 years of age. … |
View full post on asthma – Google News